Logo Logo
Group by: Item Type | Date
Number of items: 8.

Journal article

Hauck, F.; Albert, M. H.; Ghosh, S.; Hoenig, M.; Nennstiel, U.; Schuetz, C.; Gramer, G.; Schulz, A. und Speckmann, C. (2022): Neugeborenenscreening auf schweren kombinierten Immundefekt. In: Monatsschrift Kinderheilkunde, Vol. 170, No. 4: pp. 328-334

Lankester, A. C.; Albert, M. H.; Booth, C.; Gennery, A. R.; Guengoer, T.; Hoenig, M.; Morris, E. C.; Moshous, D.; Neven, B.; Schulz, A.; Slatter, M. und Veys, P. (2021): EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity. In: Bone Marrow Transplantation, Vol. 56, No. 9: pp. 2052-2062

Schuetz, C.; Hauck, F.; Albert, M. H.; Hoenig, M.; Borte, S.; Wahn, V.; Schulz, A.; Nennstiel, U. und Speckmann, C. (2019): Neugeborenenscreening auf schwere kombinierte Immundefekte. Wichtigste Fakten für Pädiater. In: Monatsschrift Kinderheilkunde, Vol. 167, No. 11: pp. 1027-1032

Wagner, B.; Albert, M. H.; Tischer, J.; Ostermann, H. und Wittmann, G. (2017): Effect of collection device on product quality in allogeneic and autologous PBSCT. In: Transfusion Medicine and Hemotherapy, Vol. 44: p. 77

Vill, K.; Müller-Felber, W.; Teusch, V.; Blaschek, A.; Gerstl, L.; Huetker, S. und Albert, M. H. (2016): Proximal muscular atrophy and weakness: An unusual adverse effect of deferasirox iron chelation therapy. In: Neuromuscular Disorders, Vol. 26, No. 4-5: pp. 322-325

Albert, M. H.; Sirin, M.; Neven, B.; Hauck, F.; Hoenig, M.; Cavazzana, M.; Fischer, A.; Schuetz, C.; Blanche, S.; Debatin, K.-M.; Klein, C.; Schulz, A. und Moshous, D. (2016): T-cell replete haploidentical bone marrow transplantation with serotherapy-containing conditioning and post-transplant cyclophosphamide for pediatric patients with non-malignant disorders. In: Bone Marrow Transplantation, Vol. 51: S459-S460

Sirin, M.; Moshous, D.; Hoenig, M.; Schuetz, C.; Neven, B.; Cavazzana, M.; Fischer, A.; Blanche, S.; Tischer, J.; Schulz, A. und Albert, M. H. (2016): T-cell replete haploidentical hematopoietic stem cell transplantation (HSCT) as salvage therapy for acute rejection/graft failure in pediatric patients with nonmalignant disorders. In: Bone Marrow Transplantation, Vol. 51: S458-S459

Conference or Workshop Item

Mizesko, M. C.; Banerjee, P. P.; Monaco-Shawver, L.; Mace, E. M.; Bernal, W.; Sawalle-Belohradsky, Julie; Belohradsky, B.; Heinz, V.; Freeman, A. F.; Sullivan, K. E.; Holland, S. M.; Torgerson, T. R.; Al-Herz, W.; Chou, J.; Hanson, I. C.; Albert, M. H.; Geha, R. S.; Renner, E. D. und Orange, J. S. (March 2013): Impaired Natural Killer Cell Function in DOCK8 Deficiency. 33. European Workshop for Rheumatology Research, Prague, Czech Republic, February 28 – March 2, 2013. Annals of the Rheumatic Diseases / Supplement. Vol. 72, No. 1 BMJ Publishing Group. A12-A13 [PDF, 66kB]

This list was generated on Sun Dec 8 01:54:38 2024 CET.